Mcgraw Benjamin F III
SEC-identified person · CIK 1216994 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Evommune, Inc. EVMN | Director | filed 2025–2026 |
| Aerie Pharmaceuticals INC AERI | Director · Interim Executive Chair | filed 2014–2022 |
| Ista Pharmaceuticals INC ISTA | Director | filed 2006–2012 |
| Valentis INC VLTS | Director · COB, President and CEO | filed 2006–2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.